DIGITAL STRATEGY
28
MindMaze has always had one mission and that ’ s to understand the brain ,” says Tej Tadi , founder and CEO of brain technology company MindMaze . “ To decode it and to connect it to the world . It ’ s not about building brain-computer interfaces , but building human-machine interfaces .”
In 2016 , that mission was aided by significant investment from the Indian conglomerate Hinduja Group , leader of a US $ 100mn funding round , which saw the company becomes Switzerland ’ s first ever tech unicorn .
MindMaze ’ s UK Market Development Director , Salim Ghoussayni , showed us two of MindMaze ’ s products in use : the MindMotion Go and the MindMotion Pro . The FDA-cleared products are virtual reality devices intended for use with patients who have sustained a neurological injury , such as that caused by a stroke .
We started with the Pro . Intended for use in a more hospital-like setting , the Pro is most effective when introduced to a patient early in the recovery cycle – indeed , introduction within days of the original incident is optimal . “ The Pro is supposed to be a platform for more intensive training ,” says Tadi . “ When someone suffers an injury or a stroke , the Pro can be by their bedside , in the intensive care unit .” Its most obvious elements are a screen and a motion tracking sensor . Depending on the severity of impairment , the method of tracking might involve light up markers attached to the arms or , when patients have a larger range of motion , markerless tracking .
JANUARY 2020